EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells

Thamir M Ismail, Rachel G Crick, Min Du, Uma Shivkumar, Andrew Carnell, Roger Barraclough iD, Guozheng Wang iD, Zhenxing Cheng, Weiping Yu iD, Angela Platt-Higgins, Gemma Nixon iD, Philip S Rudland

Biomolecules · 10.07.2023 · 13 (7) · 1099

DOI: 10.3390/biom13071099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.07.2023. Verfasst von Thamir M Ismail und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Systems Biology, University of Liverpool, Liverpool L69 7ZB, UK. Hauptthemen laut MEDLINE: S100 Calcium-Binding Protein A4, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, Cancer and Polio Research Fund, Wirral UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most patients who die of cancer do so from its metastasis to other organs. The calcium-binding protein S100A4 can induce cell migration/invasion and metastasis in experimental animals and is overexpressed in most human metastatic cancers. Here, we report that a novel inhibitor of S100A4 can specifically block its increase in cell migration in rat (IC50, 46 µM) and human (56 µM) triple negative breast cancer (TNBC) cells without affecting Western-blotted levels of S100A4. The moderately-weak S100A4-inhibitory compound, US-10113 has been chemically attached to thalidomide to stimulate the proteasomal machinery of a cell. This proteolysis targeting chimera (PROTAC) RGC specifically eliminates S100A4 in the rat (IC50, 8 nM) and human TNBC (IC50, 3.2 nM) cell lines with a near 20,000-fold increase in efficiency over US-10113 at inhibiting cell migration (IC50, 1.6 nM and 3.5 nM, respectively). Knockdown of S100A4 in human TNBC cells abolishes this effect. When PROTAC RGC is injected with mouse TNBC cells into syngeneic Balb/c mice, the incidence of experimental lung metastases or local primary tumour invasion and spontaneous lung metastasis is reduced in the 10–100 nM concentration range (Fisher’s Exact test, p ≤ 0.024). In conclusion, we have established proof of principle that destructive targeting of S100A4 provides the first realistic chemotherapeutic approach to selectively inhibiting metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

S100 Calcium-Binding Protein A4Triple Negative Breast NeoplasmsAnimalsHumansMiceRatsCell Line, TumorCell MovementNeoplasm InvasivenessNeoplasm MetastasisProteolysis Targeting Chimera

Stichwörter der Autor:innen

PROTAC destructionS100A4inhibition of migration/metastasistriple negative breast cancer

Substanzen

S100 Calcium-Binding Protein A4S100A4 protein, humanProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Department of Biochemistry and Systems Biology, University of Liverpool, Liverpool L69 7ZB, UK.
  • Department of Chemistry, University of Liverpool, Liverpool L69 7ZB, UK.
  • Department of Clinical Infection, Microbiology and Immunity, University of Liverpool, Liverpool L69 7ZB, UK.
  • Medical School, Southeast University, Nanjing 230032, China.
  • Department of Gastroenterology, First Affiliated Hospital, Anhui Medical University, Hefei 210009, China.

ORCID-Profile: Roger Barraclough, Guozheng Wang, Weiping Yu, Gemma Nixon

Förderung

  • Cancer Research UK
  • Medical Research Council
  • Cancer and Polio Research Fund, Wirral UK
  • Medical Research Council UK
  • Engineering and Physical Sciences Research Council UK

Zitieren

APA

Ismail, T. M., Crick, R. G., Du, M., Shivkumar, U., Carnell, A., Barraclough, R., Wang, G., Cheng, Z., Yu, W., Platt-Higgins, A., Nixon, G., & Rudland, P. S. (2023). Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells. Biomolecules, 13(7), 1099. https://doi.org/10.3390/biom13071099

Vancouver

Ismail TM, Crick RG, Du M, Shivkumar U, Carnell A, Barraclough R, et al. Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells. Biomolecules. 2023;13(7):1099. doi:10.3390/biom13071099

BibTeX
@article{Ismail2023,
  author = {Ismail, Thamir M and Crick, Rachel G and Du, Min and Shivkumar, Uma and Carnell, Andrew and Barraclough, Roger and Wang, Guozheng and Cheng, Zhenxing and Yu, Weiping and Platt-Higgins, Angela and Nixon, Gemma and Rudland, Philip S},
  title = {Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {7},
  pages = {1099},
  doi = {10.3390/biom13071099}
}
Kostenlos starten →